Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

BSX

Boston Scientific (BSX)

Boston Scientific Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:BSX
일자시간출처헤드라인심볼기업
2024/04/2420:31IH Market NewsU.S. Futures Display Mixed Results Amid Earnings, WTI and Brent Crude Prices Dip in June Futures TradingNYSE:BSXBoston Scientific Corporation
2024/04/2419:30PR Newswire (US)Boston Scientific Announces Results for First Quarter 2024NYSE:BSXBoston Scientific Corporation
2024/04/0813:00PR Newswire (US)Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software ModuleNYSE:BSXBoston Scientific Corporation
2024/04/0121:00PR Newswire (US)Boston Scientific Announces Conference Call Discussing First Quarter 2024 ResultsNYSE:BSXBoston Scientific Corporation
2024/03/0120:55PR Newswire (US)Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated BalloonNYSE:BSXBoston Scientific Corporation
2024/02/2806:15PR Newswire (US)Boston Scientific Announces Completion of €2.0 Billion Offering of Senior NotesNYSE:BSXBoston Scientific Corporation
2024/02/2311:27PR Newswire (US)Boston Scientific Announces Pricing of €2.0 Billion of Senior NotesNYSE:BSXBoston Scientific Corporation
2024/02/0522:00PR Newswire (US)Boston Scientific to Participate in TD Cowen's 44th Annual Health Care ConferenceNYSE:BSXBoston Scientific Corporation
2024/01/3120:30PR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NYSE:BSXBoston Scientific Corporation
2024/01/3120:29IH Market NewsU.S. Futures Waver Ahead of Fed Decision Amid Mixed Corporate Earnings; Oil Prices SlideNYSE:BSXBoston Scientific Corporation
2024/01/3120:25PR Newswire (US)Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation SystemNYSE:BSXBoston Scientific Corporation
2024/01/0906:55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NYSE:BSXBoston Scientific Corporation
2024/01/0901:36Dow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNYSE:BSXBoston Scientific Corporation
2024/01/0821:41Dow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNYSE:BSXBoston Scientific Corporation
2024/01/0821:00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NYSE:BSXBoston Scientific Corporation
2024/01/0821:00Business WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNYSE:BSXBoston Scientific Corporation
2024/01/0522:00PR Newswire (US)Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 ResultsNYSE:BSXBoston Scientific Corporation
2023/12/2906:00PR Newswire (US)Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial FibrillationNYSE:BSXBoston Scientific Corporation
2023/11/1723:00PR Newswire (US)Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.NYSE:BSXBoston Scientific Corporation
2023/11/0121:00PR Newswire (US)Boston Scientific to Participate in Stifel's 2023 Healthcare ConferenceNYSE:BSXBoston Scientific Corporation
2023/10/2619:30PR Newswire (US)BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023NYSE:BSXBoston Scientific Corporation
2023/10/2606:18AllPennyStocks.comMicrocap Offers Unique Opportunity for Investors In $10 Billion SCI IndustryNYSE:BSXBoston Scientific Corporation
2023/10/2604:32Dow Jones NewsBoston Scientific Gets Positive Results for Heart-Failure DeviceNYSE:BSXBoston Scientific Corporation
2023/10/2603:29PR Newswire (US)Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE TrialNYSE:BSXBoston Scientific Corporation
2023/10/2504:18PR Newswire (US)REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS™ Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary EmbolismNYSE:BSXBoston Scientific Corporation
2023/10/1200:19Dow Jones NewsBoston Scientific Down Over 6%, on Pace for Largest Percent Decrease Since May 2022 -- Data TalkNYSE:BSXBoston Scientific Corporation
2023/10/0219:30PR Newswire (US)Boston Scientific Announces Conference Call Discussing Third Quarter 2023 ResultsNYSE:BSXBoston Scientific Corporation
2023/09/2119:45PR Newswire (US)CVS Health appoints Michael F. Mahoney to its Board of DirectorsNYSE:BSXBoston Scientific Corporation
2023/09/1920:45Dow Jones NewsBoston Scientific to Buy Relievant Medsystems for Initial $800 MillionNYSE:BSXBoston Scientific Corporation
2023/09/1920:00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.NYSE:BSXBoston Scientific Corporation
 검색 관련기사 보기:NYSE:BSX